Anti-proliferative Activity of Hibiscus sabdariffa L. Calyx Flavonoid Extracts on Cervical Cancer Cells using Flow Cytometry

groupview

Abstract
Pharmacognosy Communications,2021,11,2,88-94.
Published:April 2021
Type:Original Article

Anti-proliferative Activity of Hibiscus sabdariffa L. Calyx Flavonoid Extracts on Cervical Cancer Cells using Flow Cytometry

Temilola Aina1, Victor Akpe2,3, Olubunmi Magbagbeola1, Ian Edwin Cock2,3,*

1Department of Biochemistry, College of Medicine (Idi-Araba), University of Lagos, NIGERIA.

2Environmental Futures Research Institute, Griffith University, Nathan Campus, QLD, AUSTRALIA.

3School of Environment and Science, Griffith University, Nathan Campus, QLD, AUSTRALIA.

Abstract:

Background: Impairment of the normal progression of the cell cycle affects the growth and development of the daughter cells, which may result in cancer cell proliferation. Herein, we investigate the effect of flavonoid fractions of Hibiscus sabdariffa L. calyx on cell cycle progression in cervical cancer cells. Methods: Flavonoids (bound and free), lipids and aqueous fractions were extracted from a methanolic extract of H. sabdariffa calyx using ethyl acetate, diethyl ether and petroleum ether. Each of these fractions were used to treat HeLa cervical cancer cells and monitored using a flow cytometer. Results: The cells exposed to the extract and its fractions had higher percentages of inactive cells (no cell division) at the quiescent (G0) and gap one phases (G1) of the cell cycle in comparison to control cells. The highest values were obtained from cells treated with the bound and free flavonoid fractions. Conclusion: The results of this study suggest that HeLa cervical cancer cell proliferation is significantly inhibited by H. sabdariffa flavonoid fractions. Daily consumption of beverages consisting of H. sabdariffa may therefore prevent the early stages of cervical cancer and inhibit the progression of the disease once it is established.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.